Skip to content
Clinitech Laboratory logo

Clinitech Laboratory

544220 BSE
Price unavailable

Clinitech Laboratory (CTLLAB) share price was ₹30.85 at the 28 Oct 2026 close; market capitalisation ₹7.04 Cr; sector Healthcare Services. The share price fell 27.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue rose 5.5% year on year to ₹4.39 Cr and net profit was ₹0.12 Cr, against ₹0.17 Cr a year earlier (compared with Mar 2025). Promoters held 64.63% of Clinitech Laboratory in Sep 2026, up 0.43 percentage points from Mar 2026.

Close 28 Oct 2026 ₹30.85 −11.15 −26.55% 1Y

Key Fundamentals

SMEHealthcare ServicesHealthcare
Market Cap
₹7.04 Cr
EBITDA
₹1.20 Cr
Return on Equity
4.48%
Debt to Equity
0.04
Book Value
₹40.52
EPS (TTM)
—
52W High
₹47.15
52W Low
₹28.55

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,906.6058.9532,002 Cr12.760.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,438.4078.9014,815 Cr15.480.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.8556.5111,403 Cr7.590.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹516.2046.598,216 Cr16.032.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹319.1046.381,662 Cr6.790.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹494.8016.231,605 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Clinitech Laboratory (this company)
——7 Cr0.760.00%4.48%6.62%——
Median 8 companies₹549.8556.517,277 Cr7.190.21%12.72%15.22%894 Cr176 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.79 times its book value

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 5.94% over last 3 years.
  • Debtor days have increased from 57.9 to 71.2 days.
  • Working capital days have increased from 99.9 days to 164 days

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
3
Bullish
4

Overall

Bearish

Bearish
12
Neutral
3
Bullish
4

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
14.12% higher than 3Y

change over 1 year

Net Income Growth
0% higher than 3Y

change over 1 year

Cash Flow Change
10.23%

change over 1 year

EBITDA Margin Change
-2.96%

change over 1 year Operating margin 10.25% · Mar 2026

Quarterly Results

Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
3.06
3.34
4.08
4.16
5.08
4.39
Expenses
2.78
2.61
3.52
3.88
4.54
3.94
Operating Profit
0.28
0.73
0.56
0.28
0.54
0.45
OPM %
9.15%
21.86%
13.73%
6.73%
10.63%
10.25%
Other Income
0.02
0.01
0.05
0.17
0.11
0.08
Interest
0.04
0.06
0.04
0.02
0.05
0.02
Depreciation
0.19
0.25
0.31
0.14
0.25
0.26
PBT
0.07
0.43
0.26
0.29
0.35
0.25
Tax %
14.29%
30.23%
15.38%
41.38%
14.29%
52%
Net Profit
0.07
0.3
0.22
0.17
0.3
0.12
EPS (₹)
0.47
1.79
0.96
0.74
1.31
0.53
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
4.55
6.38
6.35
6.4
8.23
9.48
Expenses
3.72
5.31
4.99
5.41
7.4
8.49
Operating Profit
0.83
1.07
1.36
0.99
0.83
0.99
OPM %
18.24%
16.77%
21.42%
15.47%
10.09%
10.44%
Other Income
0.04
0.07
0.02
0.04
0.23
0.19
Interest
0.08
0.06
0.07
0.09
0.06
0.07
Depreciation
0.25
0.38
0.45
0.44
0.45
0.51
PBT
0.54
0.7
0.86
0.5
0.55
0.6
Tax %
25.93%
27.14%
29.07%
26%
29.09%
30%
Net Profit
0.4
0.51
0.61
0.37
0.39
0.42
EPS (₹)
2.67
3.4
4.07
2.2
1.71
1.84
Div. Payout %
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.67
1.5
1.5
1.68
2.28
2.28
Reserves
0.72
0.35
0.88
1.87
6.55
6.97
Borrowings
0.54
0.89
1.03
0.87
0
0.36
Other Liabilities
0.8
0.94
2.62
1.19
2.01
1.3
Total Liabilities
2.73
3.68
6.03
5.61
10.84
10.91
Fixed Assets
0.84
1.65
1.33
1.71
2.12
2.18
CWIP
0.08
0.41
0.56
0.94
1.01
0.99
Investments
0.09
0.14
2.02
0.07
0.07
0.08
Other Assets
1.72
1.48
2.12
2.89
7.64
7.66
Total Assets
2.73
3.68
6.03
5.61
10.84
10.91
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.38
0.96
1.25
-1.28
-0.88
-0.9
Investing
0.54
-1.47
-0.65
0.75
-0.73
-0.44
Financing
-0.88
0.29
0.09
0.45
3.98
0.33
Net Cash Flow
0.04
-0.22
0.68
-0.08
2.37
-1.01
Free Cash Flow
0.19
-0.55
0.97
-2.49
-1.73
-1.45
CFO/EBITDA
64
109
114
-115
-87
-70
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
44.92
20.6
28.17
34.22
68.3
71.23
Inventory Days
32.21
40.28
43.68
92.91
—
—
Days Payable
165
131
125
116
—
—
Cash Conversion Cycle
-87.48
-70.03
-52.95
10.99
68.3
71.23
Working Capital Days
43.32
-4.58
-33.34
21.67
114
164
ROCE %
—
32.55%
30.24%
14.81%
8.15%
7.27%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Clinitech Laboratory insights

55 extracted metrics + investor summaries across FY15–FY26.

Shareholding Pattern

FIIs0.32%Promot.64.63%DIIs0.63%Others1.67%Public32.76%As ofSep 2026

Documents

Frequently Asked Questions about Clinitech Laboratory

What does Clinitech Laboratory Ltd do?
Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.[1]
Where is Clinitech Laboratory Ltd (CTLLAB) listed?
Clinitech Laboratory Ltd trades under code 544220 on the BSE.
Which sector does Clinitech Laboratory Ltd belong to?
Clinitech Laboratory Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd has a market capitalisation of ₹7.04 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Clinitech Laboratory Ltd?
Over the last 52 weeks Clinitech Laboratory Ltd has traded between ₹28.55 and ₹47.15 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd reported a return on equity of 4.48%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.[1]

Website ctllab.in
Listed 2024-08-01
Face Value ₹ 10
Shares Outstanding 22,81,250

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544220.md for Clinitech Laboratory Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month